“Too Young” and “Just Aging”: What Women Hear When They Raise Perimenopause
“Too Young” and “Just Aging”: What Women Hear When They Raise Perimenopause
A new national survey and peer-reviewed research show most women meet resistance when they name perimenopause. Here is what the data say and how clinicians close the gap.
Women in perimenopause often spend months searching for an explanation before anyone names the cause. When they raise perimenopause with a clinician, many hear they are too young or their symptoms reflect normal aging.
A July 2026 survey from ThisIsMenopause, an online community operated by MyHealthTeam, puts numbers to this experience. The survey polled 1,000 U.S. women ages 35 to 59 in perimenopause. Health.com covered the results on November 1, 2026. This article draws on the original survey release and peer-reviewed research.
What the Survey Found
Four numbers frame the problem.
82%
first blamed their symptoms on anxiety, burnout, or everyday stress.
72%
met pushback from clinicians, friends, or family when they suggested perimenopause.
47%
of women ages 35 to 39 were told they were too young.
76%
had to raise perimenopause with their provider themselves.
- Most women missed the cause at first. Only 14% recognized perimenopause right away. 16% took more than a year to make the connection.
- Early symptoms were subtle. Women most often named mood changes, poor sleep, fatigue, and menstrual changes as their first signs. Hot flashes, the best-known symptom, did not lead the list.
- Pushback took familiar forms. 40% were told their symptoms reflected aging. 24% were told they were too young.
- Feeling heard shaped the visit. Of the 815 respondents who discussed symptoms with a provider, 55% found the conversation helpful. Among women who found the visit helpful, 53% said their provider took them seriously. Among women who did not, 19% said so.
- Treatment advice conflicted. 38% received conflicting or questionable advice, most often about hormone replacement therapy (HRT). Several respondents named outdated safety data from the early 2000s as the reason they delayed HRT for years.
- Women wanted more. 43% wished for more discussion of treatment options. 42% said a symptom tracker or discussion guide would have improved the visit.
Peer-Reviewed Research Shows the Same Pattern
A study of 7,640 U.S. women confirms the findings.
Researchers from Flo Health and Mayo Clinic surveyed 7,640 U.S. women ages 35 and older. They published the results in Menopause, the journal of The Menopause Society, in July 2026.
- 34% of participants did not know their reproductive stage.
- Uncertainty peaked at 42% among women ages 40 to 44.
- Free-text responses identified three drivers: symptom confusion (56%), knowledge gaps (28%), and barriers to confirmation and care, including dismissive encounters (16%).
Clinical Pearl
The study authors urge clinicians to stop relying on irregular cycles as the main sign of perimenopause. Many women develop symptoms before their cycles change.
Why Perimenopause Goes Unrecognized
Four factors delay recognition.
No lab test confirms it
Hormone levels swing from week to week. Diagnosis rests on age, symptoms, and menstrual history.
Symptoms overlap
Premenstrual syndrome, thyroid disease, and mental health conditions share many of the same signs.
Training lags
In a 2022 national survey, 31.3% of obstetrics and gynecology residency program directors reported a menopause curriculum. 29.3% gave trainees dedicated menopause clinic time.
Guidance is new
In September 2026, Obstetrics & Gynecology published a clinician toolkit on hormonal options. The authors note perimenopause lacks specific guidelines.
What This Means for Practice
Whole-person care fits this diagnosis.
Osteopathic medicine treats the whole person. Perimenopause calls for this approach. The diagnosis rests on the full pattern of sleep, mood, cognitive, and menstrual changes. No single lab value replaces a careful history.
Ask early
Ask about perimenopause symptoms from a patient's late 30s onward, with or without cycle changes.
Replace reflex answers with a workup
Swap “too young” and “normal aging” for a structured history and a full differential diagnosis.
Give it a dedicated visit
Annual exams leave little time for perimenopause. Invite patients to track symptoms beforehand, and review the log together.
Correct HRT misinformation
The Menopause Society 2022 position statement finds a favorable benefit-risk ratio for most healthy symptomatic women younger than 60 or within 10 years of menopause onset.
Decide together
Present hormonal and nonhormonal options, and build the plan with the patient.
What Patients Should Do
Four steps lead to a more productive appointment.
- Track symptoms for four weeks. Note sleep, mood, hot flashes, memory, and cycle changes.
- Book an appointment dedicated to these symptoms.
- Name perimenopause directly, and ask how your clinician plans to evaluate it.
- Seek a second opinion if you feel dismissed. The Menopause Society lists Menopause Society Certified Practitioners (MSCPs) in its online directory, and many ACOOG members are included.
About the Data
ThisIsMenopause fielded its survey online through a Qualtrics panel in July 2026. Responses are self-reported. The survey has not undergone peer review, and its results describe respondents rather than all U.S. women. MyHealthTeam, a Swoop company, operates ThisIsMenopause. The company is ad-supported and states it holds no financial stake in any treatment. Flo Health researchers led the Menopause study in collaboration with Mayo Clinic.
Sharpen your menopause care.
Explore ACOOG continuing medical education (CME) on midlife women's health.
References
- ThisIsMenopause. For 82% of women, stress and burnout were the first answer, not perimenopause [press release]. August 26, 2026. thisismenopause.com
- ThisIsMenopause. Perimenopause survey data fact sheet. July 2026. View fact sheet (PDF)
- Xu Y, Fergus D, Hewings-Martin Y, et al. Exploring prevalence and drivers of perimenopause uncertainty among US women: a mixed-methods study. Menopause. 2026. doi:10.1097/GME.0000000000002837
- The Menopause Society. Many women still confused about perimenopause [press release]. July 15, 2026. menopause.org
- Piasta J, Zewail A. Hormonal options for perimenopause: a clinician toolkit. Obstet Gynecol. 2026;148(5):571-583. doi:10.1097/AOG.0000000000006436
- Allen JT, Laks S, Zahler-Miller C, et al. Needs assessment of menopause education in United States obstetrics and gynecology residency training programs. Menopause. 2023;30(10):1002-1005. doi:10.1097/GME.0000000000002234
- The 2022 Hormone Therapy Position Statement Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. PubMed 35797481
- Witmer SA. Nearly a quarter of women in perimenopause were told they were too young, survey finds. Health.com. November 1, 2026. health.com
acoog blog
Questions or story ideas? Contact ACOOG Education.
Lifelong learning in women's health. ∞